On 2025-05-08, Silence Therapeutics PLC Sponsored ADR (SLN) announced earnings per share of $-0.60 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.18.
The next expected annoucement date for quarterly earnings is 2025-08-21, with an average estimated earnings per share of $-0.28 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.18 | $-0.60 |
| 2025-02-27 | 2024-12-31 | $-0.45 | $0.27 |
| 2024-11-14 | 2024-09-30 | $-0.42 | $-0.75 |
| 2024-08-15 | 2024-06-30 | $-0.32 | $-0.42 |
| 2024-05-16 | 2024-03-31 | $-0.23 | $-0.05 |
| 2024-03-13 | 2023-12-31 | $-0.25 | $-0.47 |
| 2023-11-14 | 2023-09-30 | $-0.56 | $-0.28 |
| 2023-08-16 | 2023-06-30 | $-0.59 | $-0.36 |
| 2023-05-16 | 2023-03-31 | $-0.51 | $-0.35 |
| 2023-03-15 | 2022-12-31 | $0.45 | $-0.46 |
| 2022-11-10 | 2022-09-30 | $-0.60 | $-0.25 |
| 2022-08-11 | 2022-06-30 | $-0.60 | $-0.50 |
| 2022-05-16 | 2022-03-31 | $-0.62 | $-0.35 |
| 2022-03-17 | 2021-12-31 | $-0.62 | $-0.42 |
| 2021-11-16 | 2021-09-30 | -- | $-0.46 |